Newsbenzinga
Indaptus Therapeutics Entered Stock Sale Agreement To Sell 20M Shares For $0.06/Share; Gross Proceeds Of $12M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…